Form 4: USCB Financial Holdings Director Receives Restricted Stock Grant
SEC Filing (Form 4)
Robert E. Kafafian, a director of USCB Financial Holdings, received a grant of 4,229 shares of restricted stock on April 22, 2024, which will vest on April 30, 2024.
Summary
- On April 22, 2024, Robert E. Kafafian, a director of USCB Financial Holdings, received 4,229 shares of restricted Class A Voting Common Stock.
- These shares were granted at a price of $0.
- The restricted stock will vest on April 30, 2024.
- Following this transaction, Kafafian beneficially owns 12,386 shares of Class A Voting Common Stock directly.
- Kafafian also holds options to purchase 5,000 shares of Class A Voting Stock at an exercise price of $14.33, which were granted on March 31, 2023, and expire on March 31, 2032.
- Robert Anderson signed the Form 4 on Kafafian's behalf under a power of attorney.
Sentiment
Score: 7
Explanation: The document reflects a standard corporate governance procedure (Form 4 filing) related to executive compensation. The grant of restricted stock is generally viewed positively as it aligns the director's interests with those of the shareholders. Therefore, the sentiment is moderately positive.
Positives
- The grant of restricted stock aligns the director's interests with those of the shareholders.
- The vesting of the shares on April 30, 2024, provides a short-term incentive for the director.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. Grants of restricted stock are a common form of executive compensation in the financial services industry.
Comparison to Industry Standards
- Comparing the size of the restricted stock grant to similar grants at comparable financial institutions would provide context on whether this grant is typical.
- Analyzing the vesting schedule against industry norms would also be beneficial.
- Companies like Bank of America, JP Morgan Chase, and Wells Fargo also use stock options and restricted stock as part of their compensation packages for directors and executives.
Stakeholder Impact
- The grant of restricted stock could have a minor positive impact on shareholder sentiment as it aligns the director's interests with those of the shareholders.
Key Dates
| Date | Description |
|---|---|
| 2023/03/31 | Grant date of stock options with an exercise price of $14.33 and an expiration date of March 31, 2032. |
| 2024/01/22 | Date of Power of Attorney execution. |
| 2024/04/22 | Date of the restricted stock grant to Robert E. Kafafian. |
| 2024/04/30 | Vesting date of the restricted stock. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.